Synergy Pharmaceuticals Inc (SGYP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Synergy Pharmaceuticals Inc (Synergy Pharma) is a biopharmaceutical company that develops and commercializes new treatments for gastrointestinal (GI) diseases. The company pioneered its R&D efforts to develop its proprietary uroguanylin-based GI platform. It is also developing analogs of uroguanylin, a naturally occurring human GI peptide that promotes normal bowel function. The companys portfolio includes Trulance (plecanatide), which is structurally identical to uroguanylin, for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) in adults. Synergy Pharmas pipeline includes dolcanatide (SP-333), an investigational candidate under evaluation for the treatment of OIC and UC. Synergy Pharma is headquartered in New York, the US.

Synergy Pharmaceuticals Inc (SGYP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Synergy Pharma Acquires FV-100 From Bristol-Myers Squibb 11
Partnerships 13
Bind Therapeutics and Synergy Pharma Enter into Research Agreement 13
Licensing Agreements 14
Cipher Pharma Enters into Licensing Agreement with Synergy Pharma 14
Synergy Pharma Enters Into Agreement With Ironwood Pharma For Plecanatide 15
Equity Offering 16
Synergy Pharma Prices Public Offering of Shares for USD56 Million 16
Synergy Pharma Raises USD125 Million in Public Offering of Shares 18
Synergy Pharma Plans to Raise Funds in Public Offering of Shares 19
Synergy Pharma Raises USD89.8 Million in Private Placement of Shares 20
Synergy Pharma Announces Public Offering Of Shares For Up To US$50 Million 21
ContraVir Pharma Spin Off from Synergy Pharma 22
Synergy Pharma Completes Public Offering Of Shares For US$90 Million 23
Synergy Pharma Completes Exercise Of Underwriters Option For Public Offering Of Shares For US$51.75 Million 25
Debt Offering 27
Synergy Pharma Raises USD79.8 Million in Private Placement of Notes Due 2019 27
Synergy Pharma Raises USD200 Million in Private Placement of 7.5% Notes Due 2019 28
Acquisition 30
Synergy Pharma Completes Acquisition Of Callisto Pharma 30
Synergy Pharmaceuticals Inc - Key Competitors 31
Synergy Pharmaceuticals Inc - Key Employees 32
Synergy Pharmaceuticals Inc - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Financial Announcements 34
May 10, 2018: Synergy Pharmaceuticals Reports First Quarter 2018 Financial Results and Business Update 34
Mar 01, 2018: Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Business Update 36
Nov 09, 2017: Synergy Pharmaceuticals Reports Third Quarter 2017 Financial Results 37
Aug 09, 2017: Synergy Pharmaceuticals Reports Second Quarter 2017 Financial Results and Business Update 38
May 10, 2017: Synergy Pharmaceuticals Reports First Quarter 2017 Financial Results and Business Update 40
Mar 01, 2017: Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update 42
Corporate Communications 44
Apr 17, 2017: Synergy Pharmaceuticals Appoints Gary G. Gemignani as Chief Financial Officer 44
Other Significant Developments 45
Oct 17, 2017: Synergy Pharmaceuticals Presents Results from Study Examining Patient and Physician Perceptions and Experiences with Irritable Bowel Syndrome with Constipation (IBS-C) 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List Of Tables

List of Tables
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synergy Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synergy Pharma Acquires FV-100 From Bristol-Myers Squibb 11
Bind Therapeutics and Synergy Pharma Enter into Research Agreement 13
Cipher Pharma Enters into Licensing Agreement with Synergy Pharma 14
Synergy Pharma Enters Into Agreement With Ironwood Pharma For Plecanatide 15
Synergy Pharma Prices Public Offering of Shares for USD56 Million 16
Synergy Pharma Raises USD125 Million in Public Offering of Shares 18
Synergy Pharma Plans to Raise Funds in Public Offering of Shares 19
Synergy Pharma Raises USD89.8 Million in Private Placement of Shares 20
Synergy Pharma Announces Public Offering Of Shares For Up To US$50 Million 21
ContraVir Pharma Spin Off from Synergy Pharma 22
Synergy Pharma Completes Public Offering Of Shares For US$90 Million 23
Synergy Pharma Completes Exercise Of Underwriters Option For Public Offering Of Shares For US$51.75 Million 25
Synergy Pharma Raises USD79.8 Million in Private Placement of Notes Due 2019 27
Synergy Pharma Raises USD200 Million in Private Placement of 7.5% Notes Due 2019 28
Synergy Pharma Completes Acquisition Of Callisto Pharma 30
Synergy Pharmaceuticals Inc, Key Competitors 31
Synergy Pharmaceuticals Inc, Key Employees 32
Synergy Pharmaceuticals Inc, Subsidiaries 33

List Of Figures

List of Figures
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Synergy Pharmaceuticals Inc (SGYP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Synergy Pharmaceuticals Inc (Synergy Pharma) is a biopharmaceutical company that develops and commercializes new treatments for gastrointestinal (GI) diseases. The company pioneered its R&D efforts to develop its proprietary uroguanylin-based

USD 250 View Report

Synergy Pharmaceuticals Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Synergy Pharmaceuticals Inc Company Profile is a detailed strategic and analytical report on Synergy Pharmaceuticals Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Constellation Pharmaceuticals Inc (CNST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Constellation Pharmaceuticals Inc (Constellation) is a clinical biopharmaceutical company that focuses to develop novel therapeutics for the treatment of serious unmet medical needs in patients with cancers associated with abnormal

USD 250 View Report

Cannabics Pharmaceuticals Inc (CNBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cannabics Pharmaceuticals Inc (Cannabics Pharmaceuticals), formerly Thrust Energy Corp, is a drug development company that develops cannabinoid-based therapies for cancer. The company develops High Content Screening (HCS) Platform, an automated

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available